[Abortion-inducing effect of intravenously administered PGF-2alpha and oxytocin in normal pregnancy and pregnancy complications (author's transl)].
D000328:Adult; D001249:Asthma / Q000150:complications; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007751:Labor, Induced; D010121:Oxytocin / Q000008:administration & dosage / Q000494:pharmacology*; D011225:Pre-Eclampsia; D011247:Pregnancy; D011248:Pregnancy Complications; D011249:Pregnancy Complications, Cardiovascular; D011273:Pregnancy, Prolonged; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D011453:Prostaglandins; D010121:Oxytocin
Der geburtsein leitende Effekt von intravenösem PGF2alpha und Oxytozin bei normalen und mit Komplikationen verbundenen Schwangerschaften